Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-03-01 @ 12:05 PM
Study NCT ID:
NCT02668757
Status:
COMPLETED
Last Update Posted:
2018-02-28
First Post:
2016-01-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HeartHab, Can a Patient-tailored Application Support Coronary Artery Disease Patients During Rehabilitation?
Sponsor:
Hasselt University
Organization:
Study Overview
Official Title:
Pilot Study, How the HeartHab Application Can Support Coronary Artery Disease Patients in Their Rehabilitation Program?
Status:
COMPLETED
Status Verified Date:
2018-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HeartHab
Brief Summary:
The HeartHab study is a pilot trial in which coronary artery disease patients (n = 15-30) are given the HeartHab application. The HeartHab application is a smarthphone based mobile application that serves as a secondary prevention tool, to support cardiac patients after their phase II cardiac rehabilitation program. During study period (4-6 weeks), participating patients will be asked to use the application. HeartHab includes a module devoted to therapy compliance, one to exercise training prescription and one to risk factor control. HeartHab aims to motivate the patient to improve his/her self-management skills and hence decrease cardiovascular morbidity (and mortality).
Motivational aspects and usability data will be collected during study period by means of app logs and/or questionnaires/interviews.
Motivational aspects and usability data will be collected during study period by means of app logs and/or questionnaires/interviews.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: